Discounted Cash Flow
DR Reddys Laboratories Ltd. ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2017 | $140.8b | $12.0b | $9.2b | 8.5% | $72.24 |
| 2018 | $2.2b (-98.5%) | $151.0m (-98.7%) | $151.0m (-98.4%) | 6.9% (-19.0%) | $0.91 (-98.7%) |
| 2019 | $2.2b (2.0%) | $325.0m (115.2%) | $415.0m (174.8%) | 14.6% (111.0%) | $1.64 (80.2%) |
| 2020 | $2.3b (4.1%) | $239.0m (-26.5%) | $332.0m (-20.0%) | 10.3% (-29.4%) | $1.56 (-4.9%) |
| 2021 | $2.6b (12.0%) | $361.0m (51.0%) | $355.0m (6.9%) | 13.9% (34.9%) | $1.42 (-9.0%) |
| 2022 | $2.8b (8.9%) | $426.0m (18.0%) | $370.0m (4.2%) | 15.1% (8.3%) | $1.87 (31.7%) |
| 2023 | $3.0b (5.9%) | $734.0m (72.3%) | $578.0m (56.2%) | 24.5% (62.7%) | $3.30 (76.5%) |
| 2024 | $3.4b (12.0%) | $862.0m (17.4%) | $348.0m (-39.8%) | 25.7% (4.9%) | $4.02 (21.8%) |
| 2025 | $3.8b (13.8%) | $663.0m (-23.1%) | $223.0m (-35.9%) | 17.4% (-32.4%) | $0.79 (-80.3%) |
| 2026 | $3.6b (-6.1%) | $42.9b (6363.0%) | $358.0m (60.5%) | 1196.9% (6780.1%) | $0.55 (-30.4%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.